# Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial

Study · id `cardio:ct-nct05366452` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05366452](<https://clinicaltrials.gov/study/NCT05366452>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05366452

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 204 participants.

## Technical summary

Registry record NCT05366452. Randomized; no masking; primary purpose other. Start 2022-12-19 (actual); primary completion 2026-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 204 participants (planned count; ClinicalTrials.gov record NCT05366452, source copy `cardio:ctgov-nct05366452-2023-01-25`, retrieved 2026-10-31)
- Started: 2022-12-19 (actual) (ClinicalTrials.gov record NCT05366452, source copy `cardio:ctgov-nct05366452-2023-01-25`, retrieved 2026-10-31)
- Primary completion: 2026-06 (anticipated) (ClinicalTrials.gov record NCT05366452, source copy `cardio:ctgov-nct05366452-2023-01-25`, retrieved 2026-10-31)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT05366452, source copy `cardio:ctgov-nct05366452-2023-01-25`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT05366452, source copy `cardio:ctgov-nct05366452-2023-01-25`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05366452-2023-01-25`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial
- Acronym: ULYSS
- Condition: Cardiogenic Shock
- Intervention (Device): IMPELLA CP
- Intervention (Other): Conventional therapy
- Lead sponsor: Assistance Publique Hopitaux De Marseille
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Registry lists this organization as the lead sponsor: Assistance Publique Hopitaux De Marseille (`cardio:org-assistance-publique-hopitaux-de-marseille`)

## Provenance

Content hash: e67f8364b3f3e472ecac1ddba06ca04dd15b51800563df6c16fb98187c3db041
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
